 A complete surveillance program for hydrazine should include systematic analysis of biologic monitoring, medical screening and morbidity/mortality information.The CDC recommends surveillance summaries and education be provided for supervisors and workers.Pre-placement and periodic medical screening should be conducted with specific focus on potential effects of hydrazine upon functioning of the eyes, skin, liver, kidneys, hematopoietic, nervous and respiratory systems.